Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus

Summary

This phase II trial is studying how well thalidomide works in treating patients with carcinosarcoma of the uterus that has come back or that does not go to remission (decrease or disappear but may still be in the body) despite treatment. Thalidomide may stop the growth of cancer by stopping blood flow to the tumor.

Timeline

Start

2001-09

Primary completion

2013-01

Completion

2013-01

Drugs

Indications